231 related articles for article (PubMed ID: 18583191)
21. Therapeutic plasma exchange in the treatment of neuroimmunologic disorders: review of 50 cases.
Yücesan C; Arslan O; Arat M; Yücemen N; Ayyildiz E; Ilhan O; Mutluer N
Transfus Apher Sci; 2007 Feb; 36(1):103-7. PubMed ID: 17224307
[TBL] [Abstract][Full Text] [Related]
22. [Long-term treatment of refractory myasthenia gravis with immunoadsorption].
Wagner S; Janzen RW; Mohs C; Pohlmann S; Klingel R; Grützmacher PW
Dtsch Med Wochenschr; 2008 Nov; 133(46):2377-82. PubMed ID: 18988129
[TBL] [Abstract][Full Text] [Related]
23. A retrospective study of complications of therapeutic plasma exchange in myasthenia.
Guptill JT; Oakley D; Kuchibhatla M; Guidon AC; Hobson-Webb LD; Massey JM; Sanders DB; Juel VC
Muscle Nerve; 2013 Feb; 47(2):170-6. PubMed ID: 23168720
[TBL] [Abstract][Full Text] [Related]
24. Therapeutic plasma exchange: Experience in a third level hospital, 2013-2016, Lima (Peru).
Palma-Garcia L; Velásquez-Rimachi V; Pezo-Pezo A; Roig J; Perez-Villegas J
J Clin Apher; 2018 Aug; 33(4):480-485. PubMed ID: 29536568
[TBL] [Abstract][Full Text] [Related]
25. Plasma exchange in France: Epidemiology 2001.
Korach JM; Petitpas D; Paris B; Bourgeade F; Passerat V; Berger P; Chillet P;
Transfus Apher Sci; 2003 Oct; 29(2):153-7. PubMed ID: 12941355
[TBL] [Abstract][Full Text] [Related]
26. World apheresis registry report.
Stegmayr B; Ptak J; Wikström B
Transfus Apher Sci; 2007 Feb; 36(1):13-6. PubMed ID: 17234456
[TBL] [Abstract][Full Text] [Related]
27. Neurologic indications for therapeutic plasma exchange: 2011 update.
Gwathmey K; Balogun RA; Burns T
J Clin Apher; 2012; 27(3):138-45. PubMed ID: 22522566
[TBL] [Abstract][Full Text] [Related]
28. Therapeutic plasma exchange for myasthenia gravis, Guillain-Barre syndrome, and other immune-mediated neurological diseases, over a 40-year experience.
Fernández-Fournier M; Kerguelen A; Rodríguez de Rivera FJ; Lacruz L; Jimeno S; Losantos I; Hernández-Maraver D; Puertas I; Tallon-Barranco A; Viejo A; Frank García A; Díez-Tejedor E
Expert Rev Neurother; 2022 Oct; 22(10):897-903. PubMed ID: 36408604
[TBL] [Abstract][Full Text] [Related]
29. Guillain-Barré syndrome treated by membrane plasma exchange and/or immunoadsorption.
Marn Pernat A; Buturović-Ponikvar J; Svigelj V; Ponikvar R
Ther Apher Dial; 2009 Aug; 13(4):310-3. PubMed ID: 19695065
[TBL] [Abstract][Full Text] [Related]
30. Overview of therapeutic plasma exchange in pediatric neurology: a single-center experience.
Özkale M; Erol I; Özkale Y; Kozanoğlu İ
Acta Neurol Belg; 2018 Sep; 118(3):451-458. PubMed ID: 29882008
[TBL] [Abstract][Full Text] [Related]
31. [Favorable results of plasmapheresis in severe myasthenia gravis].
Blom RJ; Kuks JB; Westerterp-Maas A; Oosterhuis HJ
Ned Tijdschr Geneeskd; 1997 Feb; 141(8):381-4. PubMed ID: 9157298
[TBL] [Abstract][Full Text] [Related]
32. Scope and application of therapeutic apheresis: Experience from a tertiary care hospital in North India.
Sharma RR; Saluja K; Jain A; Dhawan HK; Thakral B; Marwaha N
Transfus Apher Sci; 2011 Dec; 45(3):239-45. PubMed ID: 22036963
[TBL] [Abstract][Full Text] [Related]
33. Evidence-based review of therapeutic plasma exchange in neurological disorders.
Chhibber V; Weinstein R
Semin Dial; 2012; 25(2):132-9. PubMed ID: 22277020
[TBL] [Abstract][Full Text] [Related]
34. Effects of replacement fluids used for therapeutic plasma exchange on plasma viscosity and plasma oncotic pressure.
Tek I; Arslan O; Arat M; Ayyildiz E; Tol M; Oral M; Ilhan O
Transfus Apher Sci; 2004 Oct; 31(2):89-93. PubMed ID: 15501412
[TBL] [Abstract][Full Text] [Related]
35. Physiological changes during and outcome following 'filtration' based continuous plasma exchange in Guillain Barre Syndrome.
Jayasena YA; Mudalige SP; Manchanayake GS; Dharmapala HL; Kumarasiri RP; Weerasinghe VS; Goonasekera CD
Transfus Apher Sci; 2010 Apr; 42(2):109-13. PubMed ID: 20122871
[TBL] [Abstract][Full Text] [Related]
36. Side effects of therapeutic plasma exchange during treatment of polyarteritis nodosa. Comparison of filtration and centrifugation. 718 sessions in 63 patients.
Lhote F; Guillevin L; Bussel A; Leon A; Lok C; Toledano D; Sobel A; Baudelot J
Life Support Syst; 1987; 5(4):359-66. PubMed ID: 2892972
[TBL] [Abstract][Full Text] [Related]
37. Complications of therapeutic plasma exchange: a prospective study of 1,727 procedures.
Shemin D; Briggs D; Greenan M
J Clin Apher; 2007; 22(5):270-6. PubMed ID: 17722046
[TBL] [Abstract][Full Text] [Related]
38. Therapeutic Plasma Exchange in Tehran Between 2011 and 2014.
Chegini A; Moghadami M; Maghary AH
Ther Apher Dial; 2020 Apr; 24(2):230-234. PubMed ID: 31177634
[TBL] [Abstract][Full Text] [Related]
39. Therapeutic plasma exchange in treatment of neuroimmunologic disorders: review of 92 cases.
Sorgun MH; Erdogan S; Bay M; Ayyıldız E; Yücemen N; Iihan O; Yücesan C
Transfus Apher Sci; 2013 Oct; 49(2):174-80. PubMed ID: 23820431
[TBL] [Abstract][Full Text] [Related]
40. Therapeutic plasma exchange in an intensive care unit (ICU): a 10-year, single-center experience.
Yilmaz AA; Can OS; Oral M; Unal N; Ayyildiz E; Ilhan O; Tulunay M
Transfus Apher Sci; 2011 Oct; 45(2):161-6. PubMed ID: 21835700
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
